Company: SINT
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-024040
Chunk: 19

Company: Sintx Technologies, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Item 8
Chunk 19
---
 
     730 
  
    Thereafter 
     1,395 
  
    Total future minimum lease payments 
     4,516 
  
    Less amounts representing interests 
     (1,096)
  
    Present value of lease liability 
     3,420 

    Current portion of operating lease liability 
     371 
  
    Long-term portion operating lease liability 
    $3,049 

12.
Related Pary Transactions

During
the three months ended June 30, 2025, the Company entered into a Research Collaboration Agreement (“Research Agreement”)
with a company that is majority owned by a shareholder of the Company. The Company paid $500,000
to fund the Research Agreement. As of June 30, 2025, the remaining prepaid balance was $163,000,
included in prepaid expenses and other current assets on the condensed consolidated balance sheets.

13.
Subsequent Events

On
July 1, 2025, the Company closed on an Asset Purchase Agreement with Sinaptic Surgical, LLC (“Sinaptic Surgical”) and
Sinaptic Holdings, LLC (“Holdings”), pursuant to which the Company agreed to purchase substantially all the assets and
assume certain liabilities of Sinaptic Surgical. As consideration for the purchase of the assets under the Asset Purchase Agreement,
the Company agreed to issue to Sinaptic Surgical warrants to purchase 325,000
shares of the Company’s common stock (the “Warrants”). The
Warrants expire five years from the date of issue and have an exercise price of $6.30
per share. The Warrants will become exercisable upon the achievement of certain milestones prior to the expiration of the
Warrants. In connection with the Asset Purchase, Sinaptic Surgical purchased 216,450
shares of the Company’s common stock at a purchase price of $3.465
per share  in a private placement.

17

ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You
should read the following discussion and analysis of our financial condition and results of operations in conjunction with our consolidated
financial statements for the year ended December 31, 2024 and the notes thereto, along with Management’s Discussion and Analysis
of Financial Condition and Results of Operations, included in our Annual Report on Form 10-K for the year ended December 31, 2024, filed
separately with the U.S. Securities and Exchange Commission. This discussion and analysis contains forward